athenahealth (ATHN) Receiving Somewhat Positive Press Coverage, Accern Reports
News headlines about athenahealth (NASDAQ:ATHN) have been trending somewhat positive on Sunday, Accern reports. Accern identifies positive and negative media coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. athenahealth earned a coverage optimism score of 0.16 on Accern’s scale. Accern also gave headlines about the health services provider an impact score of 46.2470705938561 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.
Here are some of the news headlines that may have impacted Accern’s analysis:
- Head-To-Head Analysis: athenahealth (ATHN) and Cotiviti (COTV) (americanbankingnews.com)
- Oversold Conditions For Athenahealth (ATHN) (nasdaq.com)
- athenahealth (ATHN) Research Coverage Started at Evercore ISI (americanbankingnews.com)
- Zacks: Analysts Expect athenahealth, Inc (ATHN) Will Announce Quarterly Sales of $322.14 Million (americanbankingnews.com)
- athenahealth, Inc (ATHN) Given Average Recommendation of “Hold” by Brokerages (americanbankingnews.com)
Several equities research analysts recently weighed in on the company. BidaskClub cut athenahealth from a “hold” rating to a “sell” rating in a research note on Tuesday, January 16th. Evercore ISI assumed coverage on athenahealth in a research report on Thursday. They set an “in-line” rating and a $140.00 price target on the stock. KeyCorp reaffirmed a “buy” rating and set a $152.00 price target on shares of athenahealth in a research report on Friday, January 12th. Oppenheimer reaffirmed a “buy” rating and set a $184.00 price target on shares of athenahealth in a research report on Friday, October 20th. Finally, Citigroup assumed coverage on athenahealth in a research report on Thursday, January 4th. They set a “neutral” rating on the stock. Two investment analysts have rated the stock with a sell rating, seventeen have assigned a hold rating and eight have assigned a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average price target of $142.96.
athenahealth (NASDAQ:ATHN) last released its earnings results on Thursday, October 19th. The health services provider reported $0.56 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.50 by $0.06. The business had revenue of $304.60 million for the quarter, compared to analyst estimates of $310.52 million. athenahealth had a return on equity of 6.78% and a net margin of 2.65%. The company’s revenue for the quarter was up 10.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.60 earnings per share. analysts expect that athenahealth will post 1.22 earnings per share for the current fiscal year.
In related news, Director David Eric Robinson sold 5,000 shares of the company’s stock in a transaction on Tuesday, January 2nd. The stock was sold at an average price of $133.94, for a total transaction of $669,700.00. Following the transaction, the director now owns 8,596 shares of the company’s stock, valued at $1,151,348.24. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Jonathan Bush sold 30,000 shares of the company’s stock in a transaction on Tuesday, December 26th. The stock was sold at an average price of $134.80, for a total value of $4,044,000.00. Following the transaction, the chief executive officer now directly owns 320,807 shares in the company, valued at approximately $43,244,783.60. The disclosure for this sale can be found here. In the last three months, insiders sold 68,900 shares of company stock worth $9,271,172. Corporate insiders own 3.20% of the company’s stock.
WARNING: “athenahealth (ATHN) Receiving Somewhat Positive Press Coverage, Accern Reports” was first reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece on another site, it was stolen and reposted in violation of U.S. and international copyright and trademark law. The original version of this piece can be read at https://www.thecerbatgem.com/2018/01/22/athenahealth-athn-receiving-somewhat-positive-press-coverage-accern-reports.html.
athenahealth Company Profile
athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.
Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.